Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/3/2020
Hy-Vee to honor veterans, active-duty military on Veterans Day with free drive-thru breakfast
Hy-Vee’s annual breakfast is being held in conjunction with Homefront Round Up, a fundraiser for charities that help veterans, active military and their families. - 11/3/2020
APhA Foundation awards incentive grants to pharmacists
The American Pharmacists Association Foundation awarded 30 pharmacists and student pharmacists $1,000 incentive grants to initiate or sustain innovative community-based projects that advance pharmacist-delivered patient care services. - 11/3/2020
IRI, Label Insight partner on enhanced media solutions to drive growth
IRI and Label Insight are expanding their partnership to provide CPG marketers with stronger tools to design marketing campaigns that drive brand growth. - 11/3/2020
Kala Pharmaceuticals gets FDA OK for Eysuvis
Kala Pharmaceuticals' Eysuvis provides a short-term treatment of the signs and symptoms for dry eye disease. - 11/3/2020
Hikma intros generic Banzel
Rufinamide oral suspension had a market value of approximately $125 million in the 12 months ended September 2020, according to IQVIA. - 11/2/2020
CVS Health supports Alzheimer's Association with in-store fundraising campaign
CVS Pharmacy customers will have the opportunity to contribute to the Alzheimer's Association this month by rounding up the change on purchases to the next dollar. - 11/2/2020
Sanofi inks deal to acquire Kiadis
Sanofi has agreed to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products. - 11/2/2020
Mylan taps Bill Szablewski as head of capital markets for Viatris
Former Bristol Myers Squibb executive Bill Szablewski will serve as head of capital markets for Viatris, the company being created by the merger of Mylan and Pfizer's Upjohn. - 11/2/2020
APhA applauds FDA’s list of essential medicines, medical countermeasures to protect Americans
The Food and Drug Administration published a list of essential medicines and medical countermeasures to ensure the American public is protected against outbreaks of emerging infectious diseases, such as COVID-19. - 11/2/2020
Akorn welcomes new board of directors
Akorn's new board appointments follow the completion of the sale of Akorn on Oct. 1.
